These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 840161)
1. Treatment of rhabdomyosarcoma in children with surgery, radiotherapy and chemotherapy. Heyn R; Holland R; Joo P; Johnson D; Newton W; Tefft M; Breslow N; Hammond D Med Pediatr Oncol; 1977; 3(1):21-32. PubMed ID: 840161 [TBL] [Abstract][Full Text] [Related]
2. The role of chemotherapy in the management of soft tissue sarcomas. Heyn RM Cancer; 1975 Mar; 35(3 suppl):921-4. PubMed ID: 1089474 [TBL] [Abstract][Full Text] [Related]
3. Combined chemotherapy in childhood rhabdomyosarcoma. Pullen DJ; Dyment PG; Hymphrey GB; Lane DM; Ragab AH Cancer Chemother Rep; 1975; 59(2 Pt 1):359-65. PubMed ID: 50123 [TBL] [Abstract][Full Text] [Related]
5. Rhabdomyosarcoma: response with chemotherapy prior to radiation in patients with gross residual disease. Tefft M; Fernandez CH; Moon TE Cancer; 1977 Feb; 39(2):665-70. PubMed ID: 319895 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study. Walterhouse DO; Lyden ER; Breitfeld PP; Qualman SJ; Wharam MD; Meyer WH J Clin Oncol; 2004 Apr; 22(8):1398-403. PubMed ID: 15007087 [TBL] [Abstract][Full Text] [Related]
7. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Flamant F; Rodary C; Rey A; Praquin MT; Sommelet D; Quintana E; Theobald S; Brunat-Mentigny M; Otten J; Voûte PA; Habrand JL; Martelli H; Barrett A; Terrier-Lacombe MJ; Oberlin O Eur J Cancer; 1998 Jun; 34(7):1050-62. PubMed ID: 9849454 [TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary treatment of embryonal rhabdomyosarcoma in children. Ghavimi F; Exelby PR; D'Angio GJ; Cham W; Lieberman PH; Tan C; Miké V; Murphy ML Cancer; 1975 Mar; 35(3):677-86. PubMed ID: 1111936 [TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy for embryonal rhabdomyosarcoma. Wilbur JR Cancer Chemother Rep; 1974; 58(2):281-4. PubMed ID: 4830502 [No Abstract] [Full Text] [Related]
10. The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children. Heyn RM; Holland R; Newton WA; Tefft M; Breslow N; Hartmann JR Cancer; 1974 Dec; 34(6):2128-42. PubMed ID: 4434341 [No Abstract] [Full Text] [Related]
11. Rhabdomyosarcoma of head and neck in children. Combination treatment by surgery, irradiation, and chemotherapy. Donaldson SS; Castro JR; Wilbur JR; Jesse RH Cancer; 1973 Jan; 31(1):26-35. PubMed ID: 4683042 [No Abstract] [Full Text] [Related]
12. The role of radiation therapy in the treatment of soft tissue sarcomas of childhood. Dritschilo A; Weichselbaum R; Cassady JR; Jaffe N; Paed D; Green D; Filler RM Cancer; 1978 Sep; 42(3):1192-203. PubMed ID: 100208 [TBL] [Abstract][Full Text] [Related]
13. The Intergroup Rhabdomyosarcoma Study-I. A final report. Maurer HM; Beltangady M; Gehan EA; Crist W; Hammond D; Hays DM; Heyn R; Lawrence W; Newton W; Ortega J Cancer; 1988 Jan; 61(2):209-20. PubMed ID: 3275486 [TBL] [Abstract][Full Text] [Related]
14. Radiotherapy and adjuvant combination chemotherapy for childhood rhabdomyosarcoma. Malpas JS; Freeman JE; Paxton A; Smith JW; Stansfeld AG; Wood CB Br Med J; 1976 Jan; 1(6004):247-9. PubMed ID: 1247806 [TBL] [Abstract][Full Text] [Related]
15. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group. Pappo AS; Lyden E; Breitfeld P; Donaldson SS; Wiener E; Parham D; Crews KR; Houghton P; Meyer WH; J Clin Oncol; 2007 Feb; 25(4):362-9. PubMed ID: 17264331 [TBL] [Abstract][Full Text] [Related]
16. Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy. Pratt CB; Hustu HO; Fleming ID; Pinkel D Cancer Res; 1972 Mar; 32(3):606-10. PubMed ID: 4551437 [No Abstract] [Full Text] [Related]
17. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936 [TBL] [Abstract][Full Text] [Related]
18. Proceedings: Combination therapy of urogenital embryonal rhabdomyosarcoma in children. Ghavimi F; Exelby PR; D'Angio GJ; Whitmore WF; Lieberman PH; Lewis JL; Miké V; Murphy ML Cancer; 1973 Nov; 32(5):1178-85. PubMed ID: 4757910 [No Abstract] [Full Text] [Related]
19. Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan AA; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS J Clin Oncol; 2014 Nov; 32(31):3547-52. PubMed ID: 25267746 [TBL] [Abstract][Full Text] [Related]
20. [Pediatric rhabdomyosarcoma of the infratemporal fossa]. Rozan O; Janot F; Oberlin O; Schwaab G; Quintana E; Tran Ba Huy P; Georges B; Luboinski B Ann Otolaryngol Chir Cervicofac; 2002 Sep; 119(4):195-201. PubMed ID: 12410115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]